Cervical Dysplasia Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
Cervical dysplasia, also known as cervical intraepithelial neoplasia (CIN), is a premalignant transformation, which is characterized by abnormal growth of cells over the surface of the cervix. This condition is curable and is not considered as cancer and ranges from mild to severe forms depending upon the concentration of abnormal cell formation. However, sometimes this disease may not require intervention and can eliminate on its own due to strong immune response, and if left untreated it may also lead to cervical cancer.
Visit Complete Report Here: http://www.marketresearchreports.biz/analysis-details/cervical-dysplasia-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019
Chronic form of cervical dysplasia is mainly caused due to infection of the cervix with sexually transmitted human papilloma viruses, especially through its 16 and 18 types. This disease is very common among females of age between 25 to 35 years of age, but it can affect women of all age groups. Cervical dysplasia can also be caused in people having multiple sex partners, early pregnancy or early child birth, and other illnesses and is often devoid of any visible symptoms, but it can be detected via human papilloma virus DNA test. Cervical dysplasia can be treated via monotherapy or combination drugs, ablation therapy and resection (removal of the abnormal area) therapy. On the basis of the degree of the condition the cervical dysplasia market can be classified into three major segments namely, mild dysplasia (CIN1), moderate dysplasia (CIN2) and severe dysplasia to cancer (CIN3).
Major driving factors for the growth of cervical dysplasia market include, increasing occurrences of various sexually transmitted diseases (STDs), increasing smoking habits, alcohol and drug abuse, increasing usage of immunosuppressant drugs and others. The...